A Study to Assess Fluent Fluid Management System vs. Aquilex Fluid Control System in Women Undergoing Myomectomy and Polypectomy Procedures

Overview

About this study

The primary objective of this study is to assess the difference in total fluid usage between the Fluent fluid management system and the Aquilex fluid control system.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Healthy female between 18 and 65 years of age.
Patient is indicated and has undergone a hysteroscopic myomectomy and/or polypectomy procedure where fluid management will be utilized.

Exclusion Criteria:

Pregnant.
Suspicion of malignancy prior to surgery.
Previously diagnosed endometrial cancer.
Submucosal Fibroids ≥ 4cm.
≥ 3 submucosal lesions (polyps and/or Fibroids).
Any contraindication for hysteroscopic surgery.
Active pelvic infection.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Christopher DeStephano, M.D., M.P.H.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Christopher DeStephano, M.D., M.P.H.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials